Once again Bioshares has a very bullish article on Invion with again a recommendation as Speculative buy Class A. This is the third article in about five months. In my experience it is totally unprecedented for any stock, let alone a quite small and friendless one, to receive anything like this much attention from the premier biotechnology magazine in Australia. This must be time to get aboard.
Add to My Watchlist
What is My Watchlist?
